Methods: Demographic and epidemiologic information was extracted from our infection control database for all laboratory identified CD cases in pediatric patients from Oct 2014-December 2017. Patients ≤ 2yo were identified as potential CD donors in a temporal-spatial model of transmission based on initial MLST analysis. CD recipients were identified as any patient with overlapping hospitalization within 12 weeks of the donor, regardless of recipient’s age. Donor-recipient pairs were further characterized with WGS to investigate the validity of presumed transmission events by epidemiologic links and MLST.
Results: During the study period CD infection (CDI) was diagnosed in 179 unique pediatric patients. 39 were ≤ 2 years. Overall MLST distribution of strains and frequency among patients ≤ 2 years is shown in Figure 1. ST-2 and 42 were the dominant strains (32% total). ST-11 was not isolated among ≤ 2 years group and only two ST-1 were isolated without identification of any related recipient cases.
Based on concordant strain type on initial MLST, 27 (69%) patients ≤ 2 years of age were identified as potential donors to 48 pediatric patients; 40 samples were recoverable for WGS representing 7 donors and 33 recipients.
Despite the high concordance on MLST, WGS revealed only one pair of related CD isolates among these based on a single nucleotide polymorphism (SNP) difference of 1. Retrospective review revealed that these patients were in adjoining rooms during an overlapping admission but were diagnosed with CDI 7 days apart.
In a pediatric oncology unit, hospitalized children ≤ 2 years of age are not a substantial reservoir for hypervirulent or epidemic strains and an infrequent source of transmission to others with spatial proximity.
T. McMillen, None
W. Huang, None
D. Chen, None
N. E. Babady, None
M. Kamboj, None